期刊文献+

七价肺炎球菌结合疫苗的安全性监测评价 被引量:2

Surveillance and Safety Evaluation of Pneumococcal 7-Valent Conjugate Vaccine
原文传递
导出
摘要 [目的]评价七价肺炎球菌结合疫苗的安全性。[方法]2010年10~11月对215名到济南市中心医院预防接种门诊接种七价肺炎球菌结合疫苗者,年龄为3个月至3岁的婴幼儿进行七价肺炎球菌结合疫苗(沛儿prevenar)接种后不良反应的临床观察,分别于接种疫苗后30min和12、24、48、72h观察不良反应,直至不良反应消失。[结果]共观察215名婴幼儿,19人(占8.84%)发生不良反应,共23例次,不良反应发生率为8.84%。3个月至1岁11个月组接种112人,发生不良反应的10人,不良反应发生率8.93%;2~3岁组接种103人,发生不良反应的9人,不良反应发生率为8.74%,二者差异无统计学意义(P>0.05)。局部反应为14例次,全身反应为9例次,均于对症治疗3日内缓解、消失。[结论]临床观察证明接种七价肺炎球菌结合疫苗有较好的安全性。 [Objective]To evaluate safety of pneumococcal 7-valent conjugate vaccine. [Methods]Clinical observation of adverse reaction was carried out for 215 children aged from 3 months to 3 years who were given pneumococcal 7-valent conjugate vaccine in immunization service department of the hospital from October to November 2010. The observation began 30 min,24 h,48 h and 72 h later after vaccination until adverse reaction disappeared. [Results]Of the 215 children,19 of them had adverse reactions, accounting for 8.84% (23 cases). The adverse reaction rate was 8.84 %, of the 112 children aged from 3 months to 1 year and llmonths,10 of them had adverse reaction, accounting for 8.93%. Of the 103 children aged from 2 to 3 years old,9 of ichem had adverse reaction, accounting for 8.74% ,there was no difference ( P 〉0.05). 14 of them had local reaction and 9 of them had systemic reaction, adverse reaction had improved and disappeared within 3 days after treatment. [Conclusion]Pneumococcal 7-Valent Conjugate vaccine is safe after clinical observation.
机构地区 济南市中心医院
出处 《预防医学论坛》 2011年第12期1135-1136,共2页 Preventive Medicine Tribune
关键词 七价肺炎球菌 结合疫苗 安全性 不良反应 Pneumococcal 7-Valent Conjugate vaccine Safety Adverse reactions
  • 相关文献

参考文献5

  • 1Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniaeco lonisation:the key to pneumococcal disease [J]. Lancetlnfect Dis, 2004,4(2/):144-154.
  • 2国家食品药品监督管理局.预防用疫苗临床试验不良反应分级标准指导原则[S].2005.
  • 3邓力,印根权.侵袭性肺炎链球菌病研究进展[J].临床儿科杂志,2009,27(1):94-97. 被引量:17
  • 4Black S, Shinefield H, Baxter R, el al . Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococ cal conjugate vaccine in Northern California Kaiser Permanente[J]. Pediatr Infect Dis J,2004,23(6) :485-489.
  • 5No authers. HHS-CDC news; direct and indirect effects of routine vaccination of children with 7-valent pnenmococcal conjugate vaccine on incidence of invasive pneumococcal disease United States, 1998 2003[J]. Ann Pharmacothers,2005,39 (11):1967-1 968.

二级参考文献11

  • 1Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill palients with pnenmococcal bacteremia [J]. Am J Respir Crit Care Med, 2004, 170(4) :440-444.
  • 2Black S, Shinefield H, Baxter R, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente [ J ]. Pediatr Infect Dis J, 2004,23 (6) : 485-489.
  • 3No authers. HHS-CDC news:direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998 -2003 [J]. Ann Pharmacothers,2005,39 (11 ) : 1967-1968.
  • 4Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease [J]. Lancet Inffect Dis,2004,4(3) : 144-154.
  • 5Myers C, Gervaix A. Streptococcus pneumoniae bacteraemia in children [J]. Int J Antimicrob Agents,2007,30(Suppl 1 ) :S24- S28.
  • 6Singleton R J, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conju- gate vaccine coverage [J]. JAMA ,2007,297(16) : 1784-1792.
  • 7Obaro S, Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines [J]. J Med Microbiol,2002,51 (2): 98-104.
  • 8Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae : epidemiology, risk factors,and clinical features [J]. Semin Respir Crit Care Med,2005,26(6) :563-574.
  • 9Davidson R, Cavalcanti R, Bruuton JL, et ol. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia [J]. N Eng J Med,2002,346(10):747-750.
  • 10Madhi SA, Klugman KP, Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia [J]. Nat Med,2004,10(8) :811-813.

共引文献26

同被引文献14

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部